Generics
EQL Pharma gains approval to sell Mellozzan in Kazakhstan
15 July 2026 - Swedish pharmaceutical company EQL Pharma AB (STO: EQL), which specialises in developing and selling generics, said on Wednesday it has secured approval for its melatonin-based product ...
Newbury Pharmaceuticals receives Swedish approval for generic tofacitinib
13 July 2026 - Swedish pharmaceutical company Newbury Pharmaceuticals AB (STO:NEWBRY) announced on Monday that it has received marketing authorisation in Sweden for Tofacitinib Newbury 5 mg and 10 mg ...
Lupin announces US launch of Azilsartan Medoxomil Tablets
18 June 2026 - India-based global pharmaceutical company Lupin Limited (BSE:500257) (NSE:LUPIN) announced on Thursday the launch of Azilsartan Medoxomil Tablets, 40mg and 80mg in the United States fol...
Breckenridge launches Tofacitinib Tablets, generic equivalent to Pfizer's Xeljanz
5 June 2026 - Breckenridge Pharmaceutical Inc, the US subsidiary of Spain-based Towa International that markets, distributes, and sells generic medicines in the United States, announced on Thursday th...
Hims & Hers expands GLP-1 offering in Canada with generic semaglutide
21 May 2026 - Health and wellness platform Hims & Hers Health Inc (NYSE:HIMS) announced on Thursday that it has launched access to generic semaglutide through its platform in Canada, marking its f...
Apotex announces commercial launch of Apo-Semaglutide Injection in Canada
15 May 2026 - Apotex Inc, a Canada-based global health company, announced on Thursday the commercial launch in Canada of Apo-Semaglutide Injection, a generic equivalent of Ozempic.The product will be ...